HEERLEN, NETHERLANDS -- (Marketwire) -- 04/19/10 --
Royal DSM N.V., the global Life Sciences and Materials Sciences company
headquartered in the Netherlands, today announces the following management
changes:
Mr. Bob Hartmayer (1952), currently President and CEO of DSM Pharmaceutical
Products, will retire after a long and successful career at DSM at the end
of
2010.
He will be succeeded by Mr. Alexander Wessels (1964), currently President
and
CEO of DSM Food Specialties. In this role he will continue to report to Mr.
Stephan Tanda, Member of the DSM Managing Board. Alexander Wessels will
work
together with Bob Hartmayer through a transition period and will assume
responsibility for DSM Pharmaceutical Products per November 1, 2010.
Mr. Hans Christian Ambjerg (1964), currently Senior Vice President Film &
Fibre
with Borealis, will succeed Alexander Wessels as President and CEO of DSM
Food
Specialties per August 1, 2010. In this role he will report toMr. Stephan
Tanda, Member of the DSM Managing Board.
Hans Christian Ambjerg, a Danish national, is highly experienced in the
health
and nutrition industry. He has built a long standing career in general
management and marketing positions with Chr. Hansen, Hercules and Danisco
all
over the world. His track record in the industry, building business and
realizing significant growth will give him an excellent starting position
to
impact the business in the Nutrition Cluster.
DSM - the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates solutions that nourish, protect and improve
performance.
Its end markets include human and animal nutrition and health, personal
care,
pharmaceuticals, automotive, coatings and paint, electrical and
electronics,
life protection and housing. DSM manages its business with a focus on the
triple
bottom line of economic prosperity, environmental quality and social
equity,
which it pursues simultaneously and in parallel. DSM has annual net sales
of
about EUR 8 billion and employs some 22,700 people worldwide. The company
is
headquartered in the Netherlands, with locations on five continents. DSM is
listed on Euronext Amsterdam. More information:www.dsm.com.
For more information:
DSM Corporate Communications DSM Investor Relations
Elvira Luykx Hans Vossen
tel. +31 (0) 45 5782035 tel. +31 (0) 45 5782864
fax +31 (0) 45 5740680 fax +31 (0) 10 4590275
e-mail: media.relations@dsm.com e-mail: investor.relations@dsm.com
[HUG#1405005]
Press release-pdf: http://hugin.info/130663/R/1405005/358985.pdf